OTC · Drug Manufacturers - Specialty & Generic

iAnthus Capital Holdings, Inc. (ITHUF) Stock

$0.00 OTC: ITHUF Healthcare

iAnthus Capital Holdings, Inc. manages and operates a network of licensed cannabis cultivation, processing, and retail dispensary facilities across the United States.

Valuation

MetricValue
Price$0.00
Market Cap$32.77M
P/E Ratio-0.53
P/B Ratio-0.28
P/S Ratio0.23
EPS (TTM)$-0.01
52-Week High$0.01
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE39.81%
ROA-3.03%
ROCE-8.04%
Gross Margin45.15%
Operating Margin-6.79%
Net Margin-42.93%
Debt/Equity-2.21
Current Ratio0.70

Annual Financials (USD)

Metric20212022202320242025
Revenue$203.0M$163.0M$159.0M$168.0M$144.0M
Operating Profit$-14.0M$-70.0M$-41.0M$-9.0M$-15.0M
Net Profit$-76.0M$-449.0M$-77.0M$-8.0M$-41.0M
EPS$-0.44$-0.07$-0.01$0.00$-0.01
Op Margin-7.0%-43.0%-25.6%-5.1%-10.1%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$347.0M$303.0M$277.0M$271.0M$256.0M
Total Liabilities$369.0M$292.0M$339.0M$337.0M$359.0M
Cash$13.0M$14.0M$13.0M$19.0M$12.0M
Borrowings$229.0M$184.0M$201.0M$210.0M$228.0M

Latest News

iAnthus Announces Results from Annual General Meeting GlobeNewswire · Jun 25, 2026 iAnthus Reports Fiscal First Quarter 2026 Financial Results GlobeNewswire · May 12, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$16.0M$-19.0M$3.0M$13.0M$3.0M
Investing Cash Flow$-42.0M$-12.0M$-10.0M$-12.0M$-21.0M
Financing Cash Flow$-1.0M$-2.0M$-1.0M$0$0
Net Cash Flow$5.0M$-2.0M$-1.0M$6.0M$-7.0M
Free Cash Flow$-4.0M$-27.0M$-3.0M$7.0M$-21.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA77.93
FCF Yield-60.89%
Quick Ratio0.25
Interest Coverage-0.61
Return 1Y-10.00%
Return 3Y-73.53%
Return 5Y-97.20%

Ownership

Insiders Held4.61%
Institutions Held76.30%
Institutions Float Held79.99%
Institutional HolderSharesReport Date
Byrne Asset Management LLC 752025-12-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CANSFAtlas Energy Corp. $0.09 +0.00% -2.10 $30.64M 0.00%
CBSTFCubeSmart $0.03 +0.00% -0.11 $14.48M 0.00%
CNTMFFluent Corp. $0.02 +8.33% -0.17 $10.35M 0.00%
CORBFGlobal Cord Blood Corporation $0.95 -0.11% 1.56 $127.22M 0.00%
ELIXFElixxer Ltd. $0.03 +0.00% -0.14 $23.35M 0.00%

About iAnthus Capital Holdings, Inc.

iAnthus Capital Holdings, Inc. manages and operates a network of licensed cannabis cultivation, processing, and retail dispensary facilities across the United States. The company's diverse product portfolio includes raw cannabis biomass such as pre-rolls, various cannabis-infused items like topical creams and edibles, and a selection of concentrated products such as vape cartridges, live resins, waxes, oils, and tinctures. They also produce and distribute a range of cannabidiol (CBD) products, including topical creams, tinctures, and sprays, alongside a dedicated line of CBD-infused beauty and skincare essentials like lotions, creams, haircare items, lip balms, and bath bombs. iAnthus participates in both the wholesale distribution and direct-to-consumer retail of its CBD offerings. Its operational footprint spans 8 states, encompassing ownership or management of 32 dispensaries and 10 cultivation or processing sites. Founded in 2014, the company is headquartered in New York, New York.

iAnthus Capital Holdings, Inc. (ITHUF) stock trades at $0.00 with a market capitalization of $32.77M. The stock is valued at a price-to-earnings (P/E) ratio of -0.53, price-to-book of -0.28, price-to-sales of 0.23. Over the past 52 weeks the stock has ranged between $0.00 and $0.01, and currently trades 100.0% below its 52-week high.

On profitability, iAnthus Capital Holdings, Inc. generates a return on equity (ROE) of 39.81% — well above the market average, a sign of a high-quality business, return on capital employed of -8.04%, an operating margin of -6.79%, a net profit margin of -42.93%.

Official website: www.ianthus.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides